CorWave

CorWave is a medical device company founded in 2012, specializing in innovative heart-assist pump technology for advanced heart failure treatment. With over 80 million euros in funding and a team of more than 90 employees, CorWave is recognized as a member of the French Tech 120, showcasing its potential in the global technology landscape. The company has developed a unique Left Ventricular Assist Device (LVAD) that utilizes undulating membrane technology, inspired by the swimming motion of aquatic animals. This device preserves the natural pulsatility of the heartbeat, working in harmony with the heart to maintain cardiovascular balance. It can automatically adjust blood flow based on the patient's activity level, enhancing patient outcomes and reducing adverse events. CorWave recently achieved a significant milestone with the world’s first implantation of its LVAD in July 2025, demonstrating its commitment to advancing heart failure treatment. CorWave's mission is to provide healthcare professionals with reliable solutions that improve the quality of life for heart failure patients. The company focuses on ongoing research and development, manufacturing, and delivering advanced heart-assist devices that support patients in leading active lives.

• Employees 93
• Founded 2012
• Annual Revenue $5400000
• Total Funding $213146004